Venigalla B. Rao

Catholic University of America — United States

Environmental Science · Physical Sciences

49h-index7.3kcitations187works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bacteriophages and microbial interactions(137), Monoclonal and Polyclonal Antibodies Research(48), RNA and protein synthesis mechanisms(43), Bacterial Genetics and Biotechnology(38), HIV Research and Treatment(29)

Publications187 total

Periplasmic gatekeeping of phage DNA entry by rSAM enzyme-mediated maturation of an effector with His-X-Ser repeats
2026Open Access
Targeted bacteriophage T4 nanoparticles reverse HIV-1 latency in human T cell line models
iScience·2025· 1 citedOpen Access
Bacteriophage T4 genome packaging: mechanism and application
EcoSal Plus·2025· 1 citedOpen Access
Cryo-EM structures of bacteriophage T4 portal-neck connector complexes reveal a viral genome retention mechanism involving a host component
2025Open Access
Green Polymers and Their Uses in Pharmacy
2025
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID‐19‐Flu Mucosal Vaccines
Small Science·2025Open Access
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID‐19‐Flu Mucosal Vaccines
Small Science·2025· 1 citedOpen Access
Corrigendum to “Facile degradation of chitosan-sodium alginate-chromium (III) gel in relation to leather re-tanning and filling” [International Journal of Biological Macromolecules, 240 (2023) 124437]
International Journal of Biological Macromolecules·2025Open Access
A Modular Bacteriophage T4 Nanoparticle Platform Enables Rapid Design of Dual COVID-19-Flu Mucosal Vaccines
2024Open Access
The role of TIR domain-containing proteins in bacterial defense against phages
Nature Communications·2024· 18 citedOpen Access
Broadly neutralizing antibodies and monoclonal V2 antibodies derived from RV305 inhibit capture and replication of HIV-1
Virology·2024Open Access
Bacteriophage T4 as a Protein-Based, Adjuvant- and Needle-Free, Mucosal Pandemic Vaccine Design Platform
Annual Review of Virology·2024· 8 citedOpen Access
A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1
eLife·2024Open Access
Author response: A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1
2024Open Access
A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1
2024Open Access
Author Response: A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1
2024Open Access
A remarkable genetic shift in a transmitted/founder virus broadens antibody responses against HIV-1
eLife·2024Open Access
A Remarkable Genetic Shift in a Transmitted/Founder Virus Broadens Antibody Responses Against HIV-1
2024Open Access
Structure-function analyses reveal key molecular determinants of HIV-1 CRF01_AE resistance to the entry inhibitor temsavir
Nature Communications·2023· 10 citedOpen Access
T4 bacteriophage nanoparticles engineered through CRISPR provide a versatile platform for rapid development of flu mucosal vaccines
Antiviral Research·2023· 12 cited
page 1 of 10Next →

Frequent Co-authors

Michael G. Rossmann(14), Tao Pan(9), Andrei Fokine(8), Zhihong Zhang(8), Kiran Kondabagil(6), Jingen Zhu(6), Marthandan Mahalingam(6), Lindsay W. Black(5), Ashok K. Chopra(5), Jian Sha(4), Stephen H. Leppla(4), Mangala Rao(4), Carl R. Alving(4), Michael Feiss(3), Valorie D. Bowman(3), Himanshu Batra(3), Siyang Sun(3), Song Gao(3), Qin Li(3), Taheri Sathaliyawala(3)